Pew Urges Improved Regulatory Framework for Controversial Dietary Supplement

Pew Urges Improved Regulatory Framework for Controversial Dietary Supplement

Pew submitted comments in December 2016 to the Drug Enforcement Agency in response to its deliberations over whether to classify the dietary supplement kratom as a schedule 1 substance, a drug with no currently accepted medical use and a high potential for abuse. Many consumers use kratom to mitigate opioid withdrawal symptoms, despite a lack of evidence that it is safe and effective and instructions for how to use it. This is especially problematic because opioid dependence is a potentially deadly disease for which there are approved medical therapies. Pew suggests that the DEA and the Food and Drug Administration work together to ensure that consumers have safe and effective treatments and understand how to use them.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?